Stem cells, organoids, and organ-on-a-chip models for personalized in vitro drug testing

Gibson, 1971, Can personalized medicine survive?, Can Fam Phys, 17, 29 R Langreth, 1999, New era of personalized medicine: targeting drugs for each unique genetic profile - PubMed, Oncologist, 4, 426, 10.1634/theoncologist.4-5-426 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 Ardalani, 2019, 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes, Acta Biomater, 95, 371, 10.1016/j.actbio.2019.07.047 Zhang, 2017, Functional characterization of human pluripotent stem cell-derived arterial endothelial cells, Proc Natl Acad Sci USA, 114, E6072 Takasato, 2015, Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis, Nature, 526, 564, 10.1038/nature15695 Park, 2008, Disease-specific induced pluripotent stem cells, Cell, 134, 877, 10.1016/j.cell.2008.07.041 Freedman, 2013, Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations, J Am Soc Nephrol, 24, 1571, 10.1681/ASN.2012111089 Brennand, 2011, Modelling schizophrenia using human induced pluripotent stem cells, Nature, 473, 221, 10.1038/nature09915 Gurevich, 2020, iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery, Biol Open, 9 Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935 Lancaster, 2014, Organogenesis in a dish: modeling development and disease using organoid technologies, Science (80), 345 Nahmias, 2006, Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro, Tissue Eng, 12, 1627, 10.1089/ten.2006.12.1627 Barker, 2010, Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro, Cell Stem Cell, 6, 25, 10.1016/j.stem.2009.11.013 Zietek, 2015, Intestinal organoids for assessing nutrient transport, sensing and incretin secretion OPEN, Nat Publ Gr Schutgens, 2019, Tubuloids derived from human adult kidney and urine for personalized disease modeling, Nat Biotechnol, 37, 303, 10.1038/s41587-019-0048-8 Kim, 2019, Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening, Nat Commun, 10, 1, 10.1038/s41467-019-11867-6 Pasch, 2019, Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation, Clin Cancer Res, 25, 5376, 10.1158/1078-0432.CCR-18-3590 Liu, 2021, Patient-derived organoid (PDO) platforms to facilitate clinical decision making, J Transl Med, 19, 1, 10.1186/s12967-020-02677-2 U.J., 2013, Idiosyncratic adverse drug reactions: current concepts, Pharmacol Rev, 65, 779, 10.1124/pr.113.007450 Gioeli, 2019, Development of a multicellular pancreatic tumor microenvironment system using patient-derived tumor cells, Lab Chip, 19, 1193, 10.1039/C8LC00755A Roller, 2021, Validation of a multicellular tumor microenvironment system for modeling patient tumor biology and drug response, Sci Rep 2021, 111, 1 Gaio, 2016, Cytostretch, an organ-on-chip platform, Micromachines, 7, 120, 10.3390/mi7070120 Wu, 2020, Organ-on-a-chip: recent breakthroughs and future prospects, Biomed Eng Online, 19, 1, 10.1186/s12938-020-0752-0 Bhatia, 2014, Microfluidic organs-on-chips, Nat Biotechnol, 32, 760, 10.1038/nbt.2989 Fan, 2016, Engineering a brain cancer chip for high-throughput drug screening, Nat Publ Gr Tao, 2019, Engineering human islet organoids from iPSCs using an organ-on-chip platform, Lab Chip, 19, 948, 10.1039/C8LC01298A Dekkers, 2013, A functional CFTR assay using primary cystic fibrosis intestinal organoids, Nat Med, 19, 939, 10.1038/nm.3201 Lu, 2018, Development of a biomimetic liver tumor-on-a-chip model based on decellularized liver matrix for toxicity testing, Lab Chip, 18, 3379, 10.1039/C8LC00852C Brown, 2015, Recreating blood-brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor, Biomicrofluidics, 9, 054124, 10.1063/1.4934713 Bauer, 2017, Functional coupling of human pancreatic islets and liver spheroids on-a-chip: towards a novel human ex vivo type 2 diabetes model, Sci Rep, 7, 14620, 10.1038/s41598-017-14815-w Trapecar, 2021, Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases, Sci Adv, 7, 10.1126/sciadv.abd1707 Trapecar, 2020, Gut-liver physiomimetics reveal paradoxical modulation of IBD-related inflammation by short-chain fatty acids, Cell Syst, 10, 223, 10.1016/j.cels.2020.02.008 Ni, 2020, Repeated dose multi-drug testing using a microfluidic chip-based coculture of human liver and kidney proximal tubules equivalents, Sci Rep, 10, 1 Rajan, 2020, Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform, Acta Biomater, 106, 124, 10.1016/j.actbio.2020.02.015 Zhang, 2017, Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors, Proc Natl Acad Sci USA, 114, E2293 Bein, 2018, Microfluidic organ-on-a-chip models of human intestine, CMGH, 5, 659 D'Costa, 2020, Biomaterials and culture systems for development of organoid and organ-on-a-chip models, Ann Biomed Eng, 48, 2002, 10.1007/s10439-020-02498-w Marx, 2020, Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development, ALTEX, 37, 364 Beaurivage, 2020, Development of a human primary gut-on-a-chip to model inflammatory processes, Sci Rep, 10, 1, 10.1038/s41598-020-78359-2 Vormann, 2021, Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies, J Pharm Sci, 110, 1601, 10.1016/j.xphs.2021.01.028 I, 2008, Automated cell culture in high density tubeless microfluidic device arrays, Lab Chip, 8, 717, 10.1039/b715375a Azizgolshani, 2021, High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows, Lab Chip, 21, 1454, 10.1039/D1LC00067E Gijzen, 2021, Culture and analysis of kidney tubuloids and perfused tubuloid cells-on-a-chip, Nat Protoc, 16, 2023, 10.1038/s41596-020-00479-w Bircsak, 2021, A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®, Toxicology, 450, 10.1016/j.tox.2020.152667 Ingber, 2020, Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies?, Adv Sci, 7, 2002030, 10.1002/advs.202002030 Mak, 2014, Lost in translation: animal models and clinical trials in cancer treatment, Am J Transl Res, 6, 114 Maass, 2019, Translational assessment of drug-induced proximal tubule injury using a kidney microphysiological system, CPT Pharmacometr Syst Pharmacol, 8, 316, 10.1002/psp4.12400 Polak, 2019, Better prediction of the local concentration–effect relationship: the role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development, Drug Discov Today, 24, 1344, 10.1016/j.drudis.2019.05.016 Gadkar, 2016, Quantitative systems pharmacology: a promising approach for translational pharmacology, Drug Discov Today Technol, 21–22, 57, 10.1016/j.ddtec.2016.11.001 Cavero, 2019, Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates, Expet Opin Drug Saf, 18, 651, 10.1080/14740338.2019.1634689 Marx, 2012, “Human-on-a-chip” developments: a translational cuttingedge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man?, ATLA Altern Lab Anim, 40, 235, 10.1177/026119291204000504